China Accelerates Brain-Computer Innovation

While Neuralink is known for brain implants, China is rapidly advancing in BCIs. Companies like NeuroXess make implants, and Gestala builds non-surgical devices. Entrepreneurs like Phoenix Peng, backed by government and investors, are driving this growth.

Phoenix Peng believes in the BCI market because China is taking real steps to support it. Provinces like Sichuan, Hubei, and Zhejiang have set prices for BCI medical services, making it easier for these devices to be covered by national health insurance.

Peng thinks BCIs will go beyond medicine. At first, they help treat diseases, but eventually they could enhance human abilities. He believes neuroscience and AI will work closely together, connecting the brain directly to AI. This could create a huge new market in the future.

China’s BCI industry is growing quickly because the government strongly supports it. They set rules, cover medical costs, and provide big funding, like the 11.6-billion-yuan brain science fund, to help companies bring BCIs to market.

China’s large patient pools and lower research costs make clinical trials faster and cheaper. With national health insurance, BCIs can be quickly used by patients once approved, unlike in the U.S., where private insurers must approve each device separately.

China has tested brain implants that let paralyzed people control devices and completed over 50 trials for movement, speech, and stroke recovery. They are now working on reading more brain signals and safer, non-surgical devices like Gestala.

China’s advanced industries in semiconductors, AI, and medical hardware make R&D and prototyping faster. At the same time, both government funds and private investors are pouring money into BCIs, boosting the market’s growth.

China’s BCI startups are growing fast to compete with U.S. companies like Neuralink, Synchron, and Paradromics. Leading Chinese firms like NeuroXess, Gestala, and BrainCo work on both implants and noninvasive devices.

China’s brain–computer interface (BCI) industry is growing quickly, with implants for accurate brain signals and non-invasive devices that are safer and easier to use. New technologies like ultrasound are opening more possibilities, and investors are supporting promising products. Regulators are tightening rules for implants but making it easier to approve non-invasive devices, while ethics and consent are becoming important.